Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Doteer Biotechnology is a specialized biotechnology company focused on the research, development, and production of core raw materials and finished kits for the in vitro diagnostics (IVD) industry. Headquartered in Jinan, China, the company provides a wide range of recombinant antigens and monoclonal antibodies targeting infectious diseases, cardiovascular markers, and inflammatory indicators. Doteer utilizes advanced platforms such as colloidal gold and fluorescence immunochromatography to develop rapid diagnostic solutions. Their business model encompasses both the supply of high-quality biological reagents to other manufacturers and the commercialization of their own diagnostic test kits. The company is recognized as a key player in the upstream IVD supply chain, supporting clinical diagnostics and research globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Doteer Biotechnology.